Market Closed -
Xetra
11:36:05 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
4.73
EUR
|
0.00%
|
|
+1.72%
|
+1.07%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
198.8
|
203.6
|
261.3
|
224.1
|
174.2
|
176.1
|
-
|
Enterprise Value (EV)
1 |
269.3
|
279
|
354.2
|
360.1
|
262.3
|
317.1
|
287.1
|
P/E ratio
|
-134
x
|
-22.8
x
|
5.2
x
|
5.23
x
|
16.7
x
|
12.1
x
|
10.3
x
|
Yield
|
-
|
-
|
-
|
1.66%
|
2.14%
|
3.17%
|
3.81%
|
Capitalization / Revenue
|
0.18
x
|
0.23
x
|
0.22
x
|
0.14
x
|
0.13
x
|
0.12
x
|
0.11
x
|
EV / Revenue
|
0.25
x
|
0.32
x
|
0.3
x
|
0.23
x
|
0.19
x
|
0.21
x
|
0.18
x
|
EV / EBITDA
|
5.09
x
|
5
x
|
2.67
x
|
2.88
x
|
2.83
x
|
3.67
x
|
3.12
x
|
EV / FCF
|
13
x
|
12.7
x
|
-31.8
x
|
-10.4
x
|
4.18
x
|
9.19
x
|
7.93
x
|
FCF Yield
|
7.71%
|
7.9%
|
-3.15%
|
-9.58%
|
23.9%
|
10.9%
|
12.6%
|
Price to Book
|
0.61
x
|
0.66
x
|
0.72
x
|
0.53
x
|
0.42
x
|
0.36
x
|
0.36
x
|
Nbr of stocks (in thousands)
|
37,222
|
37,222
|
37,222
|
37,222
|
37,222
|
37,222
|
-
|
Reference price
2 |
5.340
|
5.470
|
7.020
|
6.020
|
4.680
|
4.730
|
4.730
|
Announcement Date
|
4/8/20
|
4/21/21
|
3/31/22
|
3/31/23
|
3/22/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1,075
|
873
|
1,188
|
1,576
|
1,352
|
1,524
|
1,590
|
EBITDA
1 |
52.9
|
55.77
|
132.5
|
124.9
|
92.7
|
86.5
|
92
|
EBIT
1 |
7.4
|
-0.346
|
81.6
|
69.6
|
30.68
|
32.1
|
36.4
|
Operating Margin
|
0.69%
|
-0.04%
|
6.87%
|
4.42%
|
2.27%
|
2.11%
|
2.29%
|
Earnings before Tax (EBT)
1 |
-1.2
|
-10.43
|
73.4
|
62
|
18.8
|
21
|
25.1
|
Net income
1 |
-1.4
|
-9.02
|
50.2
|
42.7
|
10.6
|
14.5
|
17.3
|
Net margin
|
-0.13%
|
-1.03%
|
4.22%
|
2.71%
|
0.78%
|
0.95%
|
1.09%
|
EPS
2 |
-0.0400
|
-0.2400
|
1.350
|
1.150
|
0.2800
|
0.3900
|
0.4600
|
Free Cash Flow
1 |
20.78
|
22.03
|
-11.14
|
-34.48
|
62.81
|
34.5
|
36.2
|
FCF margin
|
1.93%
|
2.52%
|
-0.94%
|
-2.19%
|
4.64%
|
2.26%
|
2.28%
|
FCF Conversion (EBITDA)
|
39.28%
|
39.51%
|
-
|
-
|
67.75%
|
39.88%
|
39.35%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
592.53%
|
237.93%
|
209.25%
|
Dividend per Share
2 |
-
|
-
|
-
|
0.1000
|
0.1000
|
0.1500
|
0.1800
|
Announcement Date
|
4/8/20
|
4/21/21
|
3/31/22
|
3/31/23
|
3/22/24
|
-
|
-
|
Fiscal Period: December |
2023 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-0.947
|
Net margin
|
-
|
EPS
2 |
-0.0300
|
Dividend per Share
|
-
|
Announcement Date
|
5/16/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
70.6
|
75.4
|
92.9
|
136
|
88.1
|
141
|
111
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.334
x
|
1.352
x
|
0.7011
x
|
1.089
x
|
0.9504
x
|
1.63
x
|
1.207
x
|
Free Cash Flow
1 |
20.8
|
22
|
-11.1
|
-34.5
|
62.8
|
34.5
|
36.2
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
8.720
|
8.260
|
9.740
|
11.40
|
11.10
|
13.00
|
13.30
|
Cash Flow per Share
|
2.580
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
74.5
|
37.1
|
46.6
|
64.7
|
53.3
|
62.4
|
65.4
|
Capex / Sales
|
6.93%
|
4.25%
|
3.92%
|
4.11%
|
3.94%
|
4.09%
|
4.11%
|
Announcement Date
|
4/8/20
|
4/21/21
|
3/31/22
|
3/31/23
|
3/22/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| +1.07% | 188M | | +5.14% | 103B | | -5.63% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|